Bayer-Backed Boundless Bio Falls After IPO
March 31, 2024 at 13:20 PM EDT
Shares of Boundless Bio fell almost 10% after raising about $100 million in the company's initial public offering. Bayer is one of the biggest investors for the therapeutics company.
